Call for Speakers - Medical Dermatology: Therapeutic R&D and Technical Innovation Conference

Cambridge Healthtech Institute (CHI) has issued a call for papers for those who would like to present at its event on November 2-4, 2016 in Philadelphia, PA. Submission deadline is April 15, 2016.
 
NEEDHAM, Mass. - March 21, 2016 - PRLog -- Skin is the largest organ and dermatology is a very unique Therapeutic Area (TA) with a breadth of indications. Now is a dynamic time for the prescription dermatological drug industry due to consolidation, rising demand for therapies, a deeper understanding of novel targets and disease pathways, genetic discoveries, antibody drug development, advanced delivery technologies, and new predictive and diagnostic technologies being utilized both in the clinic and for translational research.

Despite the scientific opportunities, continued burden to patients with unmet medical needs, and growing market demand, there are hurdles for developing new therapies. So, where should companies focus their resources? How can this broader research community work together to share knowledge and bring new therapies to market and to the patients who need them? What are key challenges and special considerations of dermatological drug development?

Cambridge Healthtech Institute's Inaugural Medical Dermatology: Therapeutic R&D and Technical Innovation conference provides a platform to discuss novel targets and disease pathways, advanced delivery technologies, new predictive and diagnostic technologies being utilized both in the clinic and for translational research, and the most promising emerging therapies.

CHI seeks high-quality papers relating to the following topics:

• Current NMEs in Dermatology, Economic Outlook of Pipelines, & (ROI) of Dermatologic Drugs

• Novel Biologicals, Genomics, Antibodies, and Receptor-Ligand Antagonists for Dermatology

• New Insights into the Skin, the Immune System, & Inflammation of the Skin

• Insights into the Biology of Skin Disease Mechanisms: Promising Pathways

• Thinking about Skin Disease beyond the Drug Asset: Early Prediction, Dx and Monitoring

• Understanding Mechanisms, Novel Targets and Pathways in Inflammatory Skin Diseases (acne, rosacea, psoriasis, atopic dermatitis, eczema), Cancer and Pre-Cancers of the Skin (SCC, BCC, AK, non-melanoma), and Scleroderma and Other Orphan Skin Diseases

• Drug Discovery and Early Development in Inflammatory Skin Diseases, Cancer and Pre-Cancers of the Skin, and Orphan Skin Diseases

• Utilizing New Tech for Med Derm Research and Development: Biomarkers, Diagnostics, Imaging, Target Engagement, Skin Pharmacokinetics (PK)

• Drug Repurposing: Screening Current Assets with Related Indications and Mechanisms to find New Markets

• Repurposing Conventional Small Molecules and New Classes of Drugs: When to Develop, Partner, License

• Advanced Drug Delivery in Dermatological Drug Development

• Agents and Technologies, Drug Penetration and Vehicles

• Translational Research and Lessons from Clinicians: An Integrated Approach to Research, Development and Commercialization

• FDA, Payer, Patient Perspectives: Understanding Regulatory, Market Access, Value Drivers and Patient Perspectives

For further details and to submit a speaker proposal online, visit http://www.healthtech.com/dermatology.

Submission Deadline is April 15, 2016.

To inquire about sponsorship and exhibit opportunities, contact: Terry Manning, Tel: 781-972-1349, tmanning@healthtech.com

About Cambridge Healthtech Institute (http://www.healthtech.com)

Cambridge Healthtech Institute (CHI), a division of Cambridge Innovation Institute, is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio held worldwide including PepTalk, Molecular Medicine Tri-Conference, SCOPE Summit, Bio-IT World Conference & Expo, PEGS Summit, Drug Discovery Chemistry, Biomarker World Congress, World Pharmaceutical Congress, Next Generation Dx Summit and Discovery on Target. CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Knowledge Foundation Bio-IT World Clinical Informatics News and Diagnostics World.

Contact
James Prudhomme
Cambridge Healthtech Institute (CHI)
jprudhomme@healthtech.com
781-972-5400
End
Cambridge Healthtech Institute PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share